T.03.7 PRELIMINARY RESULTS ON SARS-COV-2 VACCINATION RESPONSE IN PATIENTS WITH COELIAC DISEASE AND NON-COELIAC ENTEROPATHIES: A SINGLE-CENTRE CASE-CONTROL STUDY

por Scalvini, D., Schiepatti, A., Maimaris, S., Muscia, R., Gregorio, V., Cosentini, E., Roda, E., Locatelli, C.A., Biagi, F.
Publicado 2022

OC.10.2 A SERUM METABOLOMICS ANALYSIS TO UNDERSTAND THE INTERPLAY BETWEEN BIOLOGICAL THERAPIES IN IBD PATIENTS AND SUSCEPTIBILITY TO SARS-COV-2 INFECTION

por Pisani, L.F., Mola, S., Crespi, G., Caprioli, F., Annunaziata, M., Manfredi, M., Pastorelli, L., Porta, C.
Publicado 2022

T.06.5 ONE YEAR OF USTEKINUMAB THERAPY IMPROVES NUTRITIONAL STATUS IN PATIENTS WITH CROHN’S DISEASE

por Bertani, L., D’Alessandro, C., Fornili, M., Coppini, F., Zanzi, F., Geri, F., Mumolo, M.G., Bellini, M., Baglietto, L., De Bortoli, N., Costa, F.
Publicado 2022

OC.15.2 HUMORAL RESPONSE TO 2-DOSE BNT162B2 MRNA VACCINE FOR COVID-19 IN LIVER TRANSPLANT RECIPIENTS

por Guarino, M., Esposito, I., Portella, G., Cossiga, V., Loperto, I., Pignata, L., Tortora, R., Attanasio, M.R., Cennamo, M., Capasso, M., Terracciano, D., Cutolo, F.M., Lanza, A.G., Lieto, R., Di Somma, S., Picciotto, F.P., Morisco, F.
Publicado 2022

T.03.10 HENOCH-SCHONLEIN PURPURA FOLLOWING EXPOSURE TO SARS-COV2 MRNA VACCINE: A CASE REPORT

por Di Vincenzo, F., Pizzoferrato, M., Bibbò, S., Ennas, S., Porcari, S., Cammarota, G.
Publicado 2022

T.03.9 MUTYH-ASSOCIATED POLYPOSIS: IS TIME TO CHANGE UPPER GI SURVEILLANCE?

por Sanchez-Mete, L., Casadio, M., Martayan, A., Stigliano, V.
Publicado 2022

T.06.3 DOES SARS-COV-2 VACCINATION AFFECT THE COURSE OF INFLAMMATORY BOWEL DISEASE IN PATIENTS ON BIOLOGICAL THERAPY?

por De Blasio, F., Montori, M., Martini, F., Paolucci, L., Vitalini, T., Pieroni, G., Quatraccioni, C., Benedetti, A.
Publicado 2022

OC.08.1 THE IMPACT OF THE COVID-19 PANDEMIC ON HOSPITALIZATIONS FOR DIVERTICULAR DISEASE

por Germana’, B., Barbiellini Amidei, C., Bellio, S., Saia, M.
Publicado 2022

T.08.5 THE OVERALL SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) PANDEMIC IMPACT ON METABOLIC (DYSFUNCTION) ASSOCIATED FATTY LIVER DISEASE. A PRELIMINARY EVALUATION

por Romeo, M., Dallio, M., Cipullo, M., Olivieri, S., Iadanza, G., Sangineto, M., Ventriglia, L., Scognamiglio, F., Federico, A.
Publicado 2022

OC.02.1 SAFETY OF COVID-19 VACCINE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: DATA OF A NATIONAL STUDY (ESCAPE-IBD)

por Todeschini, A., Contaldo, A., Macaluso, F.S., Facciotti, F., Castiglione, F., Nardone, O.M., Spagnuolo, R., Doldo, P., Riguccio, G., Conforti, F.S., Viganò, C., Ascolani, M., Bodini, G., Milla, M., Scardino, G., Vernero, M., Desideri, F., Mannino, M., Rizzo, G., Di Leo, A., Orlando, A., Principi, M.
Publicado 2022

PC.01.4 REDUCED IMMUNE RESPONSE INDUCED BY TWO DOSES OF COVID-19 VACCINE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: DATA FROM ESCAPE - AN IG-IBD STUDY

por Macaluso, F.S., Principi, M., Facciotti, F., Contaldo, A., Todeschini, A., Saibeni, S., Bezzio, C., Castiglione, F., Nardone, O.M., Spagnuolo, R., Doldo, P., Fantini, M.C., Paba, S., Riguccio, G., Conforti, F.S., Viganò, C., Ascolani, M., Bodini, G., Milla, M., Scardina, G., Vernero, M., Desideri, F., Mannino, M., Rizzo, G., Caprioli, F.A., Orlando, A.
Publicado 2022

T.07.7 INCREASED NUMBER OF COLORECTAL INTERVAL CANCERS IN LYNCH SYNDROME AFTER THE SARS-COV-2 PANDEMIC. A SURVEY-BASED STUDY

por Mannucci, A., Puzzono, M., Russo, M., Barchi, A., Zuppardo, R.A., Biamonte, P., Bencardino, S., Leandro, G., Cannizzaro, R., Monica, F., Zagari, R.M., Pasquale, L., Goni, E., Di Leo, M., Ricciardiello, L., Cavestro, G.M.
Publicado 2022

OC.02.2 REDUCED EXPRESSION OF SARS-COV-2 INFECTION-RELATED GENES IN INFLAMMATORY BOWEL DISEASE PATIENTS

por Pisani, L.F., Mola, S., Crespi, G., Caprioli, F., Annunziata, M., Porta, C., Pastorelli, L.
Publicado 2022

T.04.10 EFFECT OF WHEY PROTEINS ON MALNUTRITION AND EXTUBATING TIME OF CRITICALLY ILL COVID-19 PATIENTS

por Fabiano, G., Scarpellini, E., Scarcella, M., Ascani, A., Zanetti, M., Luzza, F., Abenavoli, L.
Publicado 2022

T.03.8 SEXUAL DYSFUNCTION IN PATIENTS WITH COELIAC DISEASE: A CROSS-SECTIONAL STUDY

por Pellegrino, R., Romano, L., Gravina, A.G., Sciorio, C., Palladino, G., Ciamarra, P., Miranda, A., Mucherino, C., Astretto, S., Pandolfo, S.D., Barone, B., Aveta, A., Napolitano, L., Imbimbo, C., Romano, M., Crocetto, F.
Publicado 2022

Covid-19 and alcohol associated liver disease

por Deutsch-Link, Sasha, Curtis, Brenda, Singal, Ashwani K.
Publicado 2022

Therapeutic adherence recorded in the outpatient follow-up of inflammatory bowel diseases in a referral center: Damages of COVID-19()

por Pellegrino, Raffaele, Pellino, Gianluca, Selvaggi, Francesco, Federico, Alessandro, Romano, Marco, Gravina, Antonietta Gerarda
Publicado 2022

Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease: Data from ESCAPE-IBD, an IG-IBD study

por Macaluso, Fabio Salvatore, Principi, Mariabeatrice, Facciotti, Federica, Contaldo, Antonella, Todeschini, Alessia, Saibeni, Simone, Bezzio, Cristina, Castiglione, Fabiana, Nardone, Olga Maria, Spagnuolo, Rocco, Fantini, Massimo Claudio, Riguccio, Gaia, Caprioli, Flavio, Viganò, Chiara, Felice, Carla, Fiorino, Gionata, Correale, Carmen, Bodini, Giorgia, Milla, Monica, Scardino, Giulia, Vernero, Marta, Desideri, Federico, Mannino, Mariella, Rizzo, Giuseppe, Orlando, Ambrogio
Publicado 2023

Intentional treatment with tofacitinib in a patient with severe refractory ulcerative colitis and concomitant Sars-CoV-2 infection

por Festa, Stefano, De Biasio, Fabiola, Aratari, Annalisa, Papi, Claudio
Publicado 2022

Chronic liver disease-related mortality in diabetes before and during the COVID-19 in the United States

por Kim, Donghee, Alshuwaykh, Omar, Dennis, Brittany B., Cholankeril, George, Knowles, Joshua W., Ahmed, Aijaz
Publicado 2023